ArticlePloS one2018

Impact of combining the progesterone receptor and preoperative endocrine prognostic index (PEPI) as a prognostic factor after neoadjuvant endocrine therapy using aromatase inhibitors in postmenopausal ER positive and HER2 negative breast cancer.

Sasagu Kurozumi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.